Anpario, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, provides the following trading update for the year ended 31 December 2020.
The Group has delivered a very strong operating performance despite a very difficult year around the world due to the pandemic. Full year sales are now expected to be not less than £30m and profit to be well ahead of expectations. This performance is reflected in the Group’s strong cash generation with year-end cash balances of £15.8m (31 Dec 2019 £13.8m) after a £1m buyback programme and in addition to increased dividend distributions.
There were strong performances in the Americas, Europe and in China where sales showed a strong recovery as farmers restocked their pig operations and the ban on the use of anti-biotic growth promoters (AGPs) in animal feed benefited sales of Orego-Stim®. The Middle East experienced continued weakness in the second half. The strongest growth was experienced in subsidiaries where local sales teams were able to fully support customers throughout the pandemic.
The Group expects to announce its preliminary results for the year ended 31 December 2020 on 17 March 2021.
New Board Appointment
Anpario has also announced the appointment of Kate Allum as a non-executive director of the company with effect from 1 February 2021.
Ms Allum has an extensive track record of senior executive and non-executive leadership roles in the food supply chain and agriculture industries. Her previous executive roles include head of European supply chain at McDonald’s Restaurants and chief executive of First Milk, the British farmer-owned dairy co-operative. Kate is currently a non-executive director of Cranswick plc, a leading UK food producer and Origin Enterprises plc, an international agri-services business.